The Efficacy and Safety of Paclitaxel Monotherapy Versus Paclitaxel-Carboplatin Combination as Neoadjuvant Chemotherapy in Advanced Ovarian Cancer With High PARK2 Expression
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
AstraZeneca
The First Affiliated Hospital with Nanjing Medical University
pharmaand GmbH
Fudan University
Hunan Cancer Hospital
AstraZeneca
Japanese Gynecologic Oncology Group
AGO Study Group